Ginzburg, the scientific director of the NitsEM named
Ginzburg, the scientific director of the NitsEM named after N.F. Gamalei under the Ministry of Health of the Russian Federation, stated in an interview with TASS that the vaccine 'Imuron-VAK' for bladder cancer may be registered in a year.
Consensus
- The vaccine 'Imuron-VAK' is being developed for bladder cancer.
- Alexander Gintsburg, scientific director of NICEM named after Gamaleya, stated that the vaccine may be registered within 12 months.
- The registration process for the drug could take between six months and one year.
- The development of the vaccine involves cooperation between NICEM and the Bashkir Federal Medical University and the First Moscow state medical university named after Sechenov.
Points of divergence
- Gintsburg previously stated that vaccines for three types of cancer will be developed in Russia. — vesti
Coverage (2 sources)
- Ginzburg said when bladder cancer vaccine may be registered — Вести
- Vaccine "Imuron-VAK" for bladder cancer may be registered in a year, said in an interview with TASS scientific head... — ТАСС (Telegram)
Key entities
- TASS
- Ginzburg
- Russia
- Ministry of Health
- Moscow
- N. F. Gamaleya National Research Center
- NITCEM named after Gamaleya
- NICTEM